Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in Herpes Simplex Virus Encephalitis
2016-004835-19Phase 3Active
- Sponsor
- CHU Grenoble Alpes
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexamethasone in herpetic meningoencephalitis (HME) (2 arms), sponsored by CHU Grenoble Alpes. Primary endpoints: Verbal memory (primary) and Verbal memory (primary extended follow-up). Started Sep 2017; status: active.
02
Drugs
dexamethasone
03
Conditions
herpetic meningoencephalitis (HME)
Beyond the preview
Go deeper on 2016-004835-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004835-19.